GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (BSP:TAKP34) » Definitions » Cyclically Adjusted PB Ratio

Takeda Pharmaceutical Co (BSP:TAKP34) Cyclically Adjusted PB Ratio : 1.20 (As of May. 28, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-05-28), Takeda Pharmaceutical Co's current share price is R$67.08. Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was R$56.07. Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.20.

The historical rank and industry rank for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSP:TAKP34' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.03   Med: 1.39   Max: 2.42
Current: 1.22

During the past years, Takeda Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 2.42. The lowest was 1.03. And the median was 1.39.

BSP:TAKP34's Cyclically Adjusted PB Ratio is ranked better than
65.8% of 693 companies
in the Drug Manufacturers industry
Industry Median: 1.86 vs BSP:TAKP34: 1.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Takeda Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was R$154.081. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$56.07 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 1.40 1.19 1.37 1.24

Takeda Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 1.40 1.41 1.21 1.24

Competitive Comparison of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=67.08/56.07
=1.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Takeda Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=154.081/107.2000*107.2000
=154.081

Current CPI (Mar. 2024) = 107.2000.

Takeda Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 66.284 98.000 72.507
201409 67.916 98.500 73.915
201412 70.202 97.900 76.871
201503 70.953 97.900 77.693
201506 69.289 98.400 75.486
201509 87.587 98.500 95.323
201512 85.179 98.100 93.080
201603 81.439 97.900 89.175
201606 75.005 98.100 81.963
201609 74.195 98.000 81.160
201612 73.113 98.400 79.652
201703 67.192 98.100 73.425
201706 76.631 98.500 83.399
201709 75.500 98.800 81.919
201712 78.932 99.400 85.126
201803 79.048 99.200 85.423
201806 89.611 99.200 96.838
201809 101.721 99.900 109.154
201812 90.311 99.700 97.105
201903 115.173 99.700 123.837
201906 111.763 99.800 120.050
201909 119.653 100.100 128.140
201912 117.665 100.500 125.509
202003 137.609 100.300 147.076
202006 144.609 99.900 155.176
202009 152.520 99.900 163.665
202012 146.963 99.300 158.655
202103 171.539 99.900 184.074
202106 152.504 99.500 164.306
202109 162.209 100.100 173.714
202112 170.046 100.100 182.107
202203 152.924 101.100 162.151
202206 153.948 101.800 162.114
202209 158.033 103.100 164.318
202212 154.464 104.100 159.064
202303 159.280 104.400 163.552
202306 152.867 105.200 155.773
202309 150.541 106.200 151.959
202312 146.237 106.800 146.785
202403 154.081 107.200 154.081

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Takeda Pharmaceutical Co  (BSP:TAKP34) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co (BSP:TAKP34) Business Description

Traded in Other Exchanges
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (BSP:TAKP34) Headlines

No Headlines